New features in MEK retinopathy

Tyagi, P; Santiago, C

Tyagi, P (reprint author), Aberdeen Royal Infirm, Dept Ophthalmol, Foresterhill Rd, Aberdeen AB25 2ZN, Scotland.

BMC OPHTHALMOLOGY, 2018; 18 ():

Abstract

Background: The use of molecularly targeted therapy is becoming widespread in oncology. These agents cause tumour-specific genetic alterations in sign......

Full Text Link